Cargando…
Can Antidiabetic Medications Affect Telomere Length in Patients with Type 2 Diabetes? A Mini-Review
The fight against aging is an eternal pursuit of humankind. The aging rate of patients with type 2 diabetes mellitus (T2DM) is higher than that of healthy individuals. Reducing the aging rate of patients with T2DM and extending their life expectancy are challenges that endocrinologists are eager to...
Autor principal: | Qin, Baoding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676684/ https://www.ncbi.nlm.nih.gov/pubmed/38028989 http://dx.doi.org/10.2147/DMSO.S428560 |
Ejemplares similares
-
A Mini Review on Antidiabetic Properties of Fermented Foods
por: Sivamaruthi, Bhagavathi Sundaram, et al.
Publicado: (2018) -
Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways
por: Zhou, Yuling, et al.
Publicado: (2016) -
Antidiabetic Potential of Marine Brown Algae—a Mini Review
por: Gunathilaka, Thilina L., et al.
Publicado: (2020) -
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
por: Dąbrowski, Mariusz
Publicado: (2021) -
The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia
por: Secnik, Juraj, et al.
Publicado: (2021)